Condor Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Condor Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,947	Closed	-$428K	–	194
2015 Q4	$428K	Sell	7,947 -369	-4%	-$19.4K	0.1%	138
2015 Q3	$410K	Sell	8,316 -12	-0.1%	-$688	0.11%	144
2015 Q2	$485K	Sell	8,328 -387	-4%	-$22.6K	0.12%	143
2015 Q1	$501K	Buy	8,715 +2,091	+32%	+$114K	0.12%	144
2014 Q4	$334K	Sell	6,624 -120	-2%	-$5.85K	0.09%	142
2014 Q3	$316K	Sell	6,744 -39	-0.6%	-$1.76K	0.09%	139
2014 Q2	$305K	Buy	+6,783	New	+$292K	0.09%	139
2013 Q4	–	Sell	-7,368	Closed	-$261K	–	161
2013 Q3	$261K	Buy	7,368 +78	+1%	+$2.75K	0.09%	140
2013 Q2	$242K	Buy	+7,290	New	+$242K	0.09%	145

Other funds holding IHE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

EAMA

EFG Asset Management (Americas) Miami, Florida $579M AUM 24.22% 1-Year Est. Return

Condor Capital Management's IHE Position: Q1 2016 in Review

Condor Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2016, closing a stake of 7,947 shares — an estimated $428K sold.

Condor Capital Management first reported a position in IHE in Q2 2013 and held it in 9 quarters. The position peaked at $501K in Q1 2015. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2016.

Condor Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Condor Capital Management sold 7,947 iShares US Pharmaceuticals ETF shares in Q1 2016, an estimated $428K.
Condor Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 9 quarters.
Condor Capital Management's iShares US Pharmaceuticals ETF position peaked at $501K in Q1 2015.
91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2016.

Based on Condor Capital Management's 13F filing for Q1 2016, filed 10 May 2016.